All Blogs
Pivot (invalidation): 104.00 Our preference Short positions below 104.00 with targets at 103.65 & 103.40 in extension. Alternative scenario Above 104.00 look for further upside with 104.20 & 104.40 as targets...
Pivot (invalidation): 1.3260 Our preference Short positions below 1.3260 with targets at 1.3210 & 1.3190 in extension. Alternative scenario Above 1.3260 look for further upside with 1.3290 & 1.3310 as targets...
Pivot (invalidation): 1.1860 Our preference Short positions below 1.1860 with targets at 1.1830 & 1.1820 in extension. Alternative scenario Above 1.1860 look for further upside with 1.1875 & 1.1890 as targets...
In the commodity market, oil prices are declining slightly after the American Petroleum Institute (API) reported a bigger-than-expected increase in US crude inventories, while disappointing retail sales data put additional pressure...
US equities took a pause on Tuesday and retreated from their record highs. While the optimism over COVID vaccines is still there, investors focused on the surging number of infections, which can lead to another series of lockdowns. Also, US retail sales data disappointed...
Pivot (invalidation): 40.85 Our preference Long positions above 40.85 with targets at 41.70 & 42.10 in extension. Alternative scenario Below 40.85 look for further downside with 40.55 & 40.05 as targets...
Pivot (invalidation): 24.6200 Our preference Short positions below 24.6200 with targets at 24.2000 & 24.0200 in extension. Alternative scenario Above 24.6200 look for further upside with 24.8300 & 24.9600 as targets...
Pivot (invalidation): 1887.00 Our preference Short positions below 1887.00 with targets at 1872.00 & 1864.00 in extension. Alternative scenario Above 1887.00 look for further upside with 1894.00 & 1899.00 as targets...
Pivot (invalidation): 3579.00 Our preference Long positions above 3579.00 with targets at 3645.00 & 3690.00 in extension. Alternative scenario Below 3579.00 look for further downside with 3552.00 & 3518.00 as targets...
Pivot (invalidation): 13000.00 Our preference Long positions above 13000.00 with targets at 13297.00 & 13460.00 in extension. Alternative scenario Below 13000.00 look for further downside with 12810.00 & 12670.00 as targets...
Pivot (invalidation): 7.6680 Our preference Long positions above 7.6680 with targets at 7.7500 & 7.7950 in extension. Alternative scenario Below 7.6680 look for further downside with 7.6200 & 7.5850 as targets...
Pivot (invalidation): 0.7305 Our preference Short positions below 0.7305 with targets at 0.7265 & 0.7240 in extension. Alternative scenario Above 0.7305 look for further upside with 0.7325 & 0.7340 as targets...
Pivot (invalidation): 1.3085 Our preference Long positions above 1.3085 with targets at 1.3125 & 1.3150 in extension. Alternative scenario Below 1.3085 look for further downside with 1.3060 & 1.3040 as targets...
Pivot (invalidation): 0.9100 Our preference Long positions above 0.9100 with targets at 0.9130 & 0.9150 in extension. Alternative scenario Below 0.9100 look for further downside with 0.9080 & 0.9060 as targets...
Pivot (invalidation): 104.30 Our preference Short positions below 104.30 with targets at 104.00 & 103.80 in extension. Alternative scenario Above 104.30 look for further upside with 104.45 & 104.60 as targets...
Pivot (invalidation): 1.3235 Our preference Long positions above 1.3235 with targets at 1.3270 & 1.3290 in extension. Alternative scenario Below 1.3235 look for further downside with 1.3210 & 1.3190 as targets...
Pivot (invalidation): 1.1875 Our preference Short positions below 1.1875 with targets at 1.1840 & 1.1825 in extension. Alternative scenario Above 1.1875 look for further upside with 1.1895 & 1.1910 as targets...
n the commodity market, oil prices continue the bullish stance amid vaccine hopes and expectations that OPEC+ will maintain the production cuts after January. Both Brent and WTI increased by more than half of a percent, trading at $41.57 and $44.11, respectively...
Wall Street extended gains on Monday, driven by reinforced vaccine optimism. After Pfizer caused the stock market to switch to value stocks and return close to its record high, now it’s time for biotech firm Moderna to give its contribution...
